Dr. Apoorva Jayarangaiah MARSHFIELD CLINIC- Saint Joseph s Hospital

Size: px
Start display at page:

Download "Dr. Apoorva Jayarangaiah MARSHFIELD CLINIC- Saint Joseph s Hospital"

Transcription

1 Dr. Apoorva Jayarangaiah MARSHFIELD CLINIC- Saint Joseph s Hospital A 30 year old G1P0 female of Korean descent was referred by her OBGYN during her 2 nd trimester to the Hematology Clinic for evaluation of persistent thrombocytopenia of 11,000. ü ü Thrombocytopenia dates back prior to pregnancy Typically, patient s platelet counts ranged from 20,000 to 30,000 1

2 } At the age of 16 Menorrhagia & Petechiae Platelet count: 10,000 Other causes excluded; HIV, EBV, autoimmune drugs, FH Peripheral smear: Giant platelets Immune thrombocytopenic purpura Bone marrow Bx: increased number of megakaryocytes with normal morphology Coagulation panel: increased BT, normal PT, PTT Immune Thrombocytopenic Purpura } She was initiated on steroids and IV immunoglobulins. } She then underwent splenectomy, as there was no response to initial treatment. } Patient was also maintained on Rituximab for a short period with no improvement. 2

3 } Menorrhagia had been controlled with oral contraceptive pills } She had received weekly injections of Romiplastin to help decrease her bleeding risk. } She was supported by repeated platelet transfusions perioperatively and during symptomatic phases. 4 years after the diagnosis of ITP, the patient presented with renal failure, hematuria and proteinuria. She quickly progressed to End Stage Renal Disease (ESRD). o Around the same time, she also developed cataracts and progressive sensorineural hearing loss. 3

4 Nephritis Alport Syndrome Cataracts hearing loss Due to presence of syndromic features of sensorineural hearing loss, renal failure and cataracts diagnosis was presumed to be Alport s syndrome Alport syndrome o Patient underwent renal transplant- living related kidney donor (from half brother). o Currently maintained on Tacrolimus and Prednisone 5 mg. 4

5 } The patient is asymptomatic. } Vital signs are within normal limits. Physical examination is normal; No petechiae or ecchymoses noted. LABAROTORY WBC: 10.3 Hemoglobin: 14.0 Hematocrit: 43 Platelet count:11,000 5

6 Macrothrombocytopenia Refractory ITP Nephritis Alport Syndrome Cataracts hearing loss Nephritis Alport s Syndrome??? Cataracts hearing loss Macrothrombocytopenia 6

7 Genetic testing ü First discovered by Epstein in 1972 ü 4 overlapping syndromes of MYH-9 disorders: Epstein Syndrome, May-Hegglin, Sebastian, Fechtner Syndrome 7

8 Non muscle myosin heavy chain gene (NMMHC-IIA) ü Present in platelets as well kidneys, leukocytes, lens and cochlea ü Important cytoskeletal contractile protein in hematopoietic stem cells - Thrombocytopenia Immune Thrombocytopenic Purpura Epstein syndrome (MYH-9 related disorders) Alport s syndrome Genetics Acquired vs congenital AD; Congenital XD; Congenital Pathogenesis Platelet-glycoprotein specific auto abs Peripheral smear Bone marrow biopsy Giant platelets (~ 10%) Increased megakaryocytes w/ normal morphology MYH-9 gene- NMMHC-IIA mutation Giant platelets; MPV Neutrophilic inclusions bodycytoplasmic aggregates of NMMHC-IIA Increased megakaryocytes w/ normal morphology Low Platelets ü ü Type IV collagen Normal - - Other clinical findings None deafness, Cataracts, Nephritis deafness, Nephritis, Cataracts, Lenticonus 8

9 } Importance of differentiating between MYH-9 gene disorders and ITP } Early recognition of MYH-9 disorders can be beneficial in avoiding unnecessary procedures, referral to genetic counseling and preventative measures } Law of diagnostic parsimony or Occam s Razor } Althaus K, Greinacher A. MYH-9 Related Platelet Disorders: Strategies for Management and Diagnosis. Transfus Med Hemother, 2010 (5); } Vassallo D, Erekosima I et al. Myosin heavy chain-9- related disorders (MYH9-RD); a case report. Clin Kidney J 2013 Oct(5); } Ryhanen SJ, Antitila P. Hereditary macrothrombocytopenia and hearing loss. Duodecim 2015; 131(9); } Kaushansky, K., & Williams, W. J. (2010). Williams hematology. New York: McGraw-Hill Medical. 9

Case Studies: Congenital Platelet Disorders

Case Studies: Congenital Platelet Disorders Case Studies: Congenital Platelet Disorders Presented to Atlanta Wednesday, November 2, 2016 Disclosures for Michele P. Lambert, MD, MTR In compliance with COI policy, ISTH requires the following disclosures

More information

QUICK REFERENCE Clinical Practice Guideline on the Evaluation and Management of Immune Thrombocytopenia (ITP)

QUICK REFERENCE Clinical Practice Guideline on the Evaluation and Management of Immune Thrombocytopenia (ITP) QUICK REFERENCE 2011 Clinical Practice Guideline on the Evaluation and Management of Immune Thrombocytopenia (ITP) Presented by the American Society of Hematology, adapted from: The American Society of

More information

V.N. KARAZIN KHARKOV NATIONAL UNIVERSITY

V.N. KARAZIN KHARKOV NATIONAL UNIVERSITY V.N. KARAZIN KHARKOV NATIONAL UNIVERSITY Kharkov Regional Centre of Cardiovascular surgery V.N. Karazin Kharkov National University Department of Internal Medicine Immune thrombocytopenic purpura Abduyeva

More information

2. Does the patient have a diagnosis of chronic idiopathic thrombocytopenic purpura (ITP)?

2. Does the patient have a diagnosis of chronic idiopathic thrombocytopenic purpura (ITP)? Pharmacy Prior Authorization MERC CARE (MEDICAID) Promacta (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and date. Fax

More information

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College AN APPROACH TO BLEEDING DISORDERS NORMAL HEMOSTASIS After injury, 3 processes halt bleeding Vasoconstriction

More information

Contemporary perspectives and initial management of pediatric ITP. William Beau Mitchell, MD Weill Cornell Medical College New York, NY USA

Contemporary perspectives and initial management of pediatric ITP. William Beau Mitchell, MD Weill Cornell Medical College New York, NY USA Contemporary perspectives and initial management of pediatric ITP William Beau Mitchell, MD Weill Cornell Medical College New York, NY USA Case Presentation 5 year old female Bruises on trunk, extremities

More information

Pharmacy Prior Authorization

Pharmacy Prior Authorization Pharmacy Prior Authorization AETA BETTER HEALTH PESLVAIA & AETA BETTER HEALTH KIDS Promacta (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review

More information

Thrombocytopenia. Dr Lynda Vandertuin May 6, 2014

Thrombocytopenia. Dr Lynda Vandertuin May 6, 2014 Dr Lynda Vandertuin May 6, 2014 1 Presentation 1. Definition 2. Platelet Physiology, Thromboiesis, & Platelet Function 3. Bleeding Risk 4. Clinical Diagnosis 5. Differential Diagnosis 6. Classification

More information

Form 2033 R3.0: Wiskott-Aldrich Syndrome Pre-HSCT Data

Form 2033 R3.0: Wiskott-Aldrich Syndrome Pre-HSCT Data Key Fields Sequence Number: Date Received: - - CIBMTR Center Number: CIBMTR Recipient ID: Has this patient's data been previously reported to USIDNET? USIDNET ID: Today's Date: - - Date of HSCT for which

More information

ITP- Immune Thrombocytopenia : A Case Report

ITP- Immune Thrombocytopenia : A Case Report Case Report ITP- Immune Thrombocytopenia : A Case Report Janice Jaison* 1, R. S. Joshi 2, S. R. Joshi 1 1 Department of Pathology, MIMER Medical College, Talegaon Dabhade, Pune, Maharashtra, India 2 Department

More information

Pharmacy Prior Authorization

Pharmacy Prior Authorization Pharmacy Prior Authorization MERC CARE (MEDICAID) Promacta (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and date. Fax

More information

Cynthia Fata, MD, MSPH 6/23/15

Cynthia Fata, MD, MSPH 6/23/15 Cynthia Fata, MD, MSPH 6/23/15 Clinical case presentation Introduction to thrombopoietin Development of thrombopoietic agents Clinical Indications Eltrombopag use in aplastic anemia Future uses 33 yo F

More information

Measuring Thrombopoietin

Measuring Thrombopoietin Measuring Thrombopoietin - 2012 A New Tool for Hematologists? Mervyn A. Sahud, M.D. A.B.I.M.-Hem. Medical Director, Coagulation Department Quest Diagnostics Nichols Institute San Juan Capistrano, CA Disclosure

More information

Acute Immune Thrombocytopenic Purpura (ITP) in Childhood

Acute Immune Thrombocytopenic Purpura (ITP) in Childhood Acute Immune Thrombocytopenic Purpura (ITP) in Childhood Guideline developed by Robert Saylors, MD, in collaboration with the ANGELS team. Last reviewed by Robert Saylors, MD September 22, 2016. Key Points

More information

Hemostatic System - general information

Hemostatic System - general information PLATELET DISORDERS Hemostatic System - general information Normal hemostatic system vessel wall circulating blood platelets blood coagulation and fibrynolysis Bleeding Diathesis inherited or acquired defects

More information

GOOD MORNING! Thursday, July Heidi Murphy, MD Leslie Carter-King, MD

GOOD MORNING! Thursday, July Heidi Murphy, MD Leslie Carter-King, MD GOOD MORNING! Thursday, July 10 2014 Heidi Murphy, MD Leslie Carter-King, MD PREP QUESTION Almost all infants experience a transient increase in bilirubin concentrations known as physiologic jaundice during

More information

EDUCATIONAL COMMENTARY PLATELET DISORDERS

EDUCATIONAL COMMENTARY PLATELET DISORDERS EDUCATIONAL COMMENTARY PLATELET DISORDERS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn

More information

Bleeding Disorders. Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph

Bleeding Disorders. Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph Bleeding Disorders Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph Normal hemostasis The normal hemostatic response involves interactions among: The blood vessel wall (endothelium)

More information

Appendix to Notification Letter for rituximab and eltrombopag dated 20 February 2014

Appendix to Notification Letter for rituximab and eltrombopag dated 20 February 2014 Appendix to Notification Letter for rituximab and eltrombopag dated 20 February 2014 The notification letter which contains details of the decision to widen the restriction criteria for rituximab and eltrombopag

More information

Miss. kamlah ahmed 1

Miss. kamlah ahmed 1 Miss. kamlah ahmed 1 Anatomy & Physiology Blood has two compartments: 1- a fluid portion called plasma. 2- a cellular portion known as the formed elements of the blood. Which are RBC (erythrocytes), WBC

More information

Platelet Disorders. By : Saja Al-Oran

Platelet Disorders. By : Saja Al-Oran Platelet Disorders By : Saja Al-Oran Introduction The platelet arise from the fragmentation of the cytoplasm of megakaryocyte in the bone marrow. circulate in the blood as disc-shaped anucleate particles

More information

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge. Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,

More information

For platelet control as individual as you

For platelet control as individual as you For platelet control as individual as you Explore the possibilities of Immune Thrombocytopenic Purpura (ITP) treatment. Important Risk Information WARNING: INTRAVASCULAR HEMOLYSIS (IVH) Intravascular hemolysis

More information

Idiopathic Thrombocytopenic Purpura

Idiopathic Thrombocytopenic Purpura Idiopathic Thrombocytopenic Purpura Title of Guideline Contact Name and Job Title (author) Directorate & Speciality Guideline for the management of idiopathic thrombocytopenic purpura Dr S Stokley, Consultant

More information

HEME 10 Bleeding Disorders

HEME 10 Bleeding Disorders HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional

More information

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate

More information

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Anemia A case-based approach David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Recognizing trends Learning Objectives MCV, RDW, Ferritin, LDH, Reticulocytes Managing complex patients 1.

More information

BLEEDING (PLATELET) DISORDER. IAP UG Teaching slides

BLEEDING (PLATELET) DISORDER. IAP UG Teaching slides BLEEDING (PLATELET) DISORDER 1 APPROACH The initial set of questions should establish the following: (1) the most common site and type of bleeding (e.g., mucocutaneous versus articular or deep muscle),

More information

Thrombocytopenia: a practial approach

Thrombocytopenia: a practial approach Thrombocytopenia: a practial approach Dr. med. Jeroen Goede FMH Innere Medizin, Medizinische Onkologie, Hämatologie FAMH Hämatologie Chefarzt Hämatologie Kantonsspital Winterthur Outline Introduction and

More information

Mayo Clin Proc, November 2003, Vol 78 Sebastian Platelet Syndrome 1417 extremities and slight hyperextensibility of hand and wrist joints, suggesting

Mayo Clin Proc, November 2003, Vol 78 Sebastian Platelet Syndrome 1417 extremities and slight hyperextensibility of hand and wrist joints, suggesting 1416 Sebastian Platelet Syndrome Mayo Clin Proc, November 2003, Vol 78 Case Report Sebastian Platelet Syndrome: A Hereditary Macrothrombocytopenia VILMARIE RODRIGUEZ, MD; WILLIAM L. NICHOLS, MD; JON E.

More information

Diagnosis and Management of Immune Thrombocytopenias. Thomas L. Ortel, M.D., Ph.D. Duke University Medical Center 2 November 2016

Diagnosis and Management of Immune Thrombocytopenias. Thomas L. Ortel, M.D., Ph.D. Duke University Medical Center 2 November 2016 Diagnosis and Management of Immune Thrombocytopenias Thomas L. Ortel, M.D., Ph.D. Duke University Medical Center 2 November 2016 Disclosures Research support: NIH, CDC, Eisai, Pfizer, Daiichi Sankyo, GlaxoSmithKline,

More information

Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN

Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN The student should be able:» To identify the mechanism of homeostasis and the role of vessels, platelets

More information

Blood Components & Indications for Transfusion. Neda Kalhor

Blood Components & Indications for Transfusion. Neda Kalhor Blood Components & Indications for Transfusion Neda Kalhor Blood products Cellular Components: Red blood cells - Leukocyte-reduced RBCs - Washed RBCs - Irradiated RBCs Platelets - Random-donor platelets

More information

BLEEDING DISORDERS Simple complement:

BLEEDING DISORDERS Simple complement: BLEEDING DISORDERS Simple complement: 1. Select the statement that describe the thrombocytopenia definition: A. Marked decrease of the Von Willebrandt factor B. Absence of antihemophilic factor A C. Disorder

More information

eltrombopag (Promacta )

eltrombopag (Promacta ) Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

PROMACTA (eltrombopag olamine) oral tablet and oral suspension

PROMACTA (eltrombopag olamine) oral tablet and oral suspension PROMACTA (eltrombopag olamine) oral tablet and oral suspension Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit

More information

INTRODUCTION TO SET FORTH APROACH TO MANAGING ADULTS TO SET FORTH APROACH PRIMARY ( PRIMARY AUTOIMMUNE) AUTOIMMUNE ITP FROM ASH & THE BRITISH

INTRODUCTION TO SET FORTH APROACH TO MANAGING ADULTS TO SET FORTH APROACH PRIMARY ( PRIMARY AUTOIMMUNE) AUTOIMMUNE ITP FROM ASH & THE BRITISH HOW I TREAT IDIOPATHIC THROMBOCYTOPENIC PURPURA Dauglas B. Cines, James B Bussel. Blood Oktober 2005:106(7):2244-22512251 INTRODUCTION TO SET FORTH APROACH TO MANAGING ADULTS PRIMARY (AUTOIMMUNE) ITP FROM

More information

The Child with a Hematologic Alteration

The Child with a Hematologic Alteration 47 The Child with a Hematologic Alteration HELPFUL HINT Review the anatomy and physiology of the hematologic system in an anatomy and physiology textbook. MATCHING KEY TERMS Match the term with the correct

More information

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,

More information

Platelet disorders. Information for families. Great Ormond Street Hospital for Children NHS Foundation Trust

Platelet disorders. Information for families. Great Ormond Street Hospital for Children NHS Foundation Trust Platelet disorders Information for families Great Ormond Street Hospital for Children NHS Foundation Trust Platelets are the cells responsible for making blood clot so platelet disorders mean that injured

More information

IMMATURE PLATELETS CLINICAL USE

IMMATURE PLATELETS CLINICAL USE HAEMATOLOGY FEBRUARY 2017 WHITE PAPER IMMATURE PLATELETS CLINICAL USE Differential diagnosis of thrombocytopenia Thrombocytopenia and automated platelet measurement Thrombocytopenia is a condition characterised

More information

Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia (CLL) Page 1 of 10 PATIENT EDUCATION Chronic Lymphocytic Leukemia (CLL) Introduction Chronic lymphocytic leukemia (CLL) is a type of cancer of the lymphocytes (a kind of white blood cell). It is also referred

More information

Neutropenia Following Intravenous Immunoglobulin Therapy in Pediatric Patients with Idiopathic Thrombocytopenic Purpura

Neutropenia Following Intravenous Immunoglobulin Therapy in Pediatric Patients with Idiopathic Thrombocytopenic Purpura ORIGINAL ARTICLE IJBC 2014;6(2): 81-85 Neutropenia Following Intravenous Immunoglobulin Therapy in Pediatric Patients with Idiopathic Thrombocytopenic Purpura Ansari S * 1, Shirali A 1, Khalili N 1, Daneshfar

More information

Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13

Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13 Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13 Mark Cunningham,MD Director, Hematology Laboratory Department of Pathology University of Kansas Medical Center College of American Pathologists

More information

Pathology note 8 BLEEDING DISORDER

Pathology note 8 BLEEDING DISORDER Pathology note 8 BLEEDING DISORDER Slide75 ( Types of clotting factors deficiency): Today we will talk about public public factor deficiency it could be acquired or inherited, acquired diseases are more

More information

Customer Information Literature List Platelets

Customer Information Literature List Platelets Customer Information Literature List Platelets Date: August 2015 Subject: Literature List Platelets Issued by: Scientific Customer Services Number: 150803 Note: Whether references are given in British

More information

Congenital bleeding disorders

Congenital bleeding disorders Congenital bleeding disorders Overview Factor VIII von Willebrand Factor Complex factor VIII von Willebrand factor (vwf) complex circulate as a complex + factor IX intrinsic pathway Platelets bind via

More information

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss Joanne Eddington, MN, FNP, AOCN Providence Oncology and Hematology Care Clinic - Eastside Blood Cell Abnormalities Abnormalities

More information

Case Report Pseudothrombocytopenia due to Platelet Clumping: A Case Report and Brief Review of the Literature

Case Report Pseudothrombocytopenia due to Platelet Clumping: A Case Report and Brief Review of the Literature Case Reports in Hematology Volume 2016, Article ID 3036476, 4 pages http://dx.doi.org/10.1155/2016/3036476 Case Report Pseudothrombocytopenia due to Platelet Clumping: A Case Report and Brief Review of

More information

DRUG NAME: Eculizumab Brand(s): Soliris DOSAGE FORM/ STRENGTH: 10 mg/ml (300 mg per vial)

DRUG NAME: Eculizumab Brand(s): Soliris DOSAGE FORM/ STRENGTH: 10 mg/ml (300 mg per vial) Preamble: A confirmed diagnosis of atypical hemolytic uremic syndrome (ahus) is required for eculizumab funding. The information below is to provide clinicians with context for how a diagnosis of ahus

More information

Dr Kannan S Consultant Hematologist Sahyadri Speciality Hospital, Pune K E M Hospital, Pune

Dr Kannan S Consultant Hematologist Sahyadri Speciality Hospital, Pune K E M Hospital, Pune IMMUNE THROMBOCYTOPENIA Dr Kannan S Consultant Hematologist Sahyadri Speciality Hospital, Pune K E M Hospital, Pune ITP Megakaryocytes Definition of ITP Primary immune thrombocytopenia Platelet count

More information

There are two main causes of a low platelet count

There are two main causes of a low platelet count Thrombocytopenia Thrombocytopenia is a condition in which a person's blood has an unusually low level of platelets Platelets, also called thrombocytes, are found in a person's blood along with red blood

More information

Bor-Sheng Ko. Hematology Division, Department of Internal Medicine, National Taiwan University Hospital

Bor-Sheng Ko. Hematology Division, Department of Internal Medicine, National Taiwan University Hospital Bor-Sheng Ko Hematology Division, Department of Internal Medicine, National Taiwan University Hospital On behalf of Members of Aplastic Anemia Consensus Meeting Diagnosis and classification: Treatment

More information

Bleeding disorders. Hemostatic failure: Inappropriate and excessive bleeding either spontaneous or in response to injury.

Bleeding disorders. Hemostatic failure: Inappropriate and excessive bleeding either spontaneous or in response to injury. 1 Bleeding disorders Objectives: 1. Discuss briefly the physiology of hemostasis. 2. Define the mechanisms of thrombocytopenia and the relative bleeding risk at any given platelet count. 3. Be able to

More information

RaDaR Inclusion and Exclusion Criteria. Diagnosis Inclusion Criteria Exclusion Criteria. Alport Syndrome definite or probable

RaDaR Inclusion and Exclusion Criteria. Diagnosis Inclusion Criteria Exclusion Criteria. Alport Syndrome definite or probable Alport Syndrome and Type IV collagenopathies APRT Deficiency Alport Syndrome definite or probable Alport carrier definite or probable Thin basement membrane nephropathy APRT Deficiency confirmed Abolished

More information

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89 Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89 Presented by Jennifer Kurkulonis 1 FOUR MAJOR TYPES OF BLOOD CELLS White blood cells

More information

Guidelines for Shared Care Centres and Community Staff

Guidelines for Shared Care Centres and Community Staff Reference: CG1410 Written by: Dr Jeanette Payne Peer reviewer Dr Jenny Welch Approved: February 2016 Approved by D&TC: 8th January 2016 Review Due: February 2019 Intended Audience This document contains

More information

UKITP INITAL INFORMATION SHEET (2.4)

UKITP INITAL INFORMATION SHEET (2.4) UKITP INITAL INFORMATION SHEET (2.4) Barts Health NHS Trust The Royal London Hospital Pathology and Pharmacy Building 80 Newark Street, London E1 2ES Centre for Haematology Institute of and Molecular Science

More information

Case Report Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report

Case Report Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report Hindawi Case Reports in Hematology Volume 2017, Article ID 3725089, 4 pages https://doi.org/10.1155/2017/3725089 Case Report Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature

More information

Chapter 06 Lecture Outline. See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes.

Chapter 06 Lecture Outline. See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Chapter 06 Lecture Outline See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Copyright 2016 McGraw-Hill Education. 2012 Pearson Permission Education,

More information

Use of Intravenous Anti-RhD Immunoglobulin (RhIG) in the Treatment of Primary Immune Thrombocytopenia

Use of Intravenous Anti-RhD Immunoglobulin (RhIG) in the Treatment of Primary Immune Thrombocytopenia Use of Intravenous Anti-RhD Immunoglobulin (RhIG) in the Treatment of Primary Immune Thrombocytopenia KRISTINA WILLIAMS ABSTRACT Commercialized intravenous immunoglobulin (IVIG) products have been used

More information

Inherited thrombocytopenia: when a low platelet count does not mean ITP

Inherited thrombocytopenia: when a low platelet count does not mean ITP Review in translational hematology Inherited thrombocytopenia: when a low platelet count does not mean ITP Jonathan G. Drachman Congenital thrombocytopenias, once considered rare and obscure conditions,

More information

* Renal insufficiencies

* Renal insufficiencies Thrombotic Thrombocytopenic Purpura Behzad Poopak, DCLS PhD. Tehran medical Branch Islamic Azad university bpoopak@yahoo.com Case Summary Ms. X, a 35-year year-old woman Complained of weakness, low grade

More information

DR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL

DR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL DR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL Rare but fatal disease if unrecognized and untreated Incidence about 1: 1 million in the USA Female preponderance of 2:1 Part

More information

ASH Draft Recommendations for Immune Thrombocytopenia

ASH Draft Recommendations for Immune Thrombocytopenia ASH Draft Recommendations for Immune Thrombocytopenia INTRODUCTION American Society of Hematology (ASH) guidelines are based on a systematic review of available evidence. Through a structured process,

More information

What You Need to Know About Blood Transfusion. Elianna Saidenberg May 2014

What You Need to Know About Blood Transfusion. Elianna Saidenberg May 2014 What You Need to Know About Blood Transfusion Elianna Saidenberg May 2014 Objectives Why your doctor might order transfusion therapy Where does the blood come from The beginning of your transfusion Consent

More information

Most Common Hemostasis Consults: Thrombocytopenia

Most Common Hemostasis Consults: Thrombocytopenia Most Common Hemostasis Consults: Thrombocytopenia Cindy Neunert, MS MSCS Assistant Professor, Pediatrics CUMC Columbia University TSHNA Meeting, April 15, 2016 Financial Disclosures No relevant financial

More information

Evaluation Of Bleeding Disorders /AAP Baton Rouge. Raj Warrier

Evaluation Of Bleeding Disorders /AAP Baton Rouge. Raj Warrier Evaluation Of Bleeding Disorders /AAP Baton Rouge Raj Warrier Evaluation and approach to management of a bleeding child Raj Warrier Ochsner /Tulane/LSU Manipal University University Of Queenland Objectives

More information

THROMBOTIC MICROANGIOPATHY. Jun-Ki Park 7/19/11

THROMBOTIC MICROANGIOPATHY. Jun-Ki Park 7/19/11 THROMBOTIC MICROANGIOPATHY Jun-Ki Park 7/19/11 TMAs are microvascular occlusive disorders characterized by systemic or intrarenal aggregation of platelets, thrombocytopenia, and mechanical injury to erythrocytes.

More information

REVIEW ARTICLE. Immune Thrombocytopenic Purpura ADARSH A K, LAKSHMI KRISHNA INTRODUCTION CLASSIFICATION

REVIEW ARTICLE. Immune Thrombocytopenic Purpura ADARSH A K, LAKSHMI KRISHNA INTRODUCTION CLASSIFICATION ADARSH A K, LAKSHMI KRISHNA REVIEW ARTICLE INTRODUCTION ITP or immune thrombocytopenic purpura is an autoimmune disorder characterized by increased platelet destruction & platelet count < 1 lakh. It is

More information

Bleeding Disorders: (Hemorrhagic Diatheses) Tests used to evaluate different aspects of hemostasis are the following:

Bleeding Disorders: (Hemorrhagic Diatheses) Tests used to evaluate different aspects of hemostasis are the following: Bleeding Disorders: (Hemorrhagic Diatheses) Excessive bleeding can result from: 1. Increased fragility of vessels. 2. Platelet deficiency or dysfunction. 3. Derangement of coagulation. 4. Combinations

More information

Interpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired

Interpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired Interpreting the CBC Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired The CBC 3 Cell Lines RBCs WBCs Platelets Assess general health Make

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Romiplostim Table of Contents Coverage Policy... 1 General Background... 2 Coding/Billing Information... 4 References... 4 Effective Date... 12/15/2017 Next

More information

GLANZMANN S THROMBASTHENIA. Stacey Shiovitz January 13, 2012

GLANZMANN S THROMBASTHENIA. Stacey Shiovitz January 13, 2012 GLANZMANN S THROMBASTHENIA Stacey Shiovitz January 13, 2012 HELP!! MY PATIENTHASGT DO YOU EVEN KNOW WHAT THAT IS? CASE 27yo woman presented tdto gynecology clinic i for menorrhagia x 10 days Bleeding started

More information

Chapter 46. Care of the Patient with a Blood or Lymphatic Disorder

Chapter 46. Care of the Patient with a Blood or Lymphatic Disorder Chapter 46 Care of the Patient with a Blood or Lymphatic Disorder All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. Components of the Blood Red

More information

Bleeding and Thrombotic Disorders. Kristine Krafts, M.D.

Bleeding and Thrombotic Disorders. Kristine Krafts, M.D. Bleeding and Thrombotic Disorders Kristine Krafts, M.D. Bleeding and Thrombotic Disorders Bleeding disorders von Willebrand disease Hemophilia A and B DIC TTP/HUS ITP Thrombotic disorders Factor V Leiden

More information

Case Workshop of Society for Hematopathology and European Association for Haematopathology

Case Workshop of Society for Hematopathology and European Association for Haematopathology Case 148 2007 Workshop of Society for Hematopathology and European Association for Haematopathology Robert P Hasserjian Department of Pathology Massachusetts General Hospital Boston, MA Clinical history

More information

Case Presentation. A Case from the Clinic. Additional Data. Examination and Data 10/27/2013

Case Presentation. A Case from the Clinic. Additional Data. Examination and Data 10/27/2013 Northwestern University Feinberg School of Medicine Treatment of Severe Thrombocytopenia in Systemic Lupus Erythematosus: The Role of New Agents Disclosures: Advisory Board: Incyte Corporation Speaker

More information

THE OLD AND THE NEW OF ITP. Alison Street Malaysia April 2010

THE OLD AND THE NEW OF ITP. Alison Street Malaysia April 2010 THE OLD AND THE NEW OF ITP Alison Street Malaysia April 2010 The Harrington-Hollingsworth Experiment Harrington et al. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic

More information

Let`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016

Let`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016 Let`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016 Case report 20 months old girl Israeli Arab Muslim family, consanguineous marriage

More information

Immune Thrombocytopenic Purpura (ITP)

Immune Thrombocytopenic Purpura (ITP) Patient information Immune Thrombocytopenic Purpura Immune Thrombocytopenic Purpura (ITP) This leaflet is for adult patients diagnosed with Immune Thrombocytopenic Purpura also known as Immune Thrombocytopenia

More information

r). SUPPLEMENTARY/SECOND OPPORTUNITY EXAMINATION PAPER nnmlbih UNIVERSITY Sophia Blaauw INSTRUCTIONS FACULTY OF HEALTH AND APPLIED SCIENCES

r). SUPPLEMENTARY/SECOND OPPORTUNITY EXAMINATION PAPER nnmlbih UNIVERSITY Sophia Blaauw INSTRUCTIONS FACULTY OF HEALTH AND APPLIED SCIENCES r). nnmlbih UNIVERSITY OF SCIEFICE nnd TECHNOLOGY FACULTY OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES QUALIFICATION: BACHELOR OF MEDICAL LABORATORY SCIENCES QUALIFICATION CODE: 08BMLS

More information

Expert Review: Updates in Immune Thrombocytopenia. Reference Slides

Expert Review: Updates in Immune Thrombocytopenia. Reference Slides Expert Review: Updates in Immune Thrombocytopenia Reference Slides Immune Thrombocytopenia (ITP): Overview ITP causality 1,2 Suboptimal platelet production Dysregulated adaptive immune system Increased

More information

Easy Bleeding General Presentation

Easy Bleeding General Presentation Easy Bleeding General Presentation It is not uncommon for children to bleed and bruise after experiencing trauma. However, a child may also have an underlying coagulopathy, which results in easy and possibly

More information

Bleeding Disorders HOPE Maram Al-anbar

Bleeding Disorders HOPE Maram Al-anbar Bleeding Disorders HOPE Maram Al-anbar 9-9 - 2014 ^^ Attention Please ^^ We ( correction team of pediatric package^hope/2010^ ) had decided to make one lecture of bleeding disorders in place of the two

More information

Thrombocytopenia with Decreased Megakaryocytes

Thrombocytopenia with Decreased Megakaryocytes Thrombocytopenia with Decreased Megakaryocytes Evaluation and Prognosis DAVID B. STOLL, M.D.; STUART BLUM, M.D.; DOMINIC PASQUALE, M.D.; and SCOTT MURPHY, M.D.; Philadelphia, Pennsylvania; Camden, New

More information

Thrombopoietin Receptor Agonists Prior Authorization with Quantity Limit Program Summary

Thrombopoietin Receptor Agonists Prior Authorization with Quantity Limit Program Summary Thrombopoietin Receptor Agonists Prior Authorization with Quantity Limit Program Summary Thrombopoietin Receptor Agonists Prior Authorization with Quantity Limit OBJECTIVE The intent of the prior authorization

More information

ACCME/Disclosures 4/13/2016. Clinical History

ACCME/Disclosures 4/13/2016. Clinical History ACCME/Disclosures The USCAP requires that anyone in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS which they or their spouse/partner

More information

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi Anemia (3).ms4.25.Oct.15 Hemolytic Anemia Abdallah Abbadi Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k, retics 12%, LDH

More information

Treatment of Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation with Eltrombopag

Treatment of Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation with Eltrombopag Treatment of Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation with Eltrombopag Kırık Melya Pelin 1, Gündeş Ilknur 1, Sarıfakıoğulları Serpil 2, Haydaroğlu Handan 2, Pehlivan Mustafa

More information

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 08/19/14 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 08/19/14 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE: RITUXAN (rituximab) Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline

More information

Bleeding Disorders.2 MS Abdallah Awidi Abbadi.MD. FRCP.FRCPath Feras Fararjeh MD

Bleeding Disorders.2 MS Abdallah Awidi Abbadi.MD. FRCP.FRCPath Feras Fararjeh MD Bleeding Disorders.2 MS4.25.02.2019 Abdallah Awidi Abbadi.MD. FRCP.FRCPath Feras Fararjeh MD Email: abdalla.awidi@gmail.com Case 6: GT 18 yr old female was admitted with pallor, abdominal pain and gum

More information

Second line therapy for ITP should be TPO agonists. Nichola Cooper Imperial Health Care NHS Trust

Second line therapy for ITP should be TPO agonists. Nichola Cooper Imperial Health Care NHS Trust Second line therapy for ITP should be TPO agonists Nichola Cooper Imperial Health Care NHS Trust COHEM 2012 Antiplatelet antibodies Platelet count after infusion with patient plasma Hours Days T cells

More information

Use of TPO mimetics for Indications Other Than ITP

Use of TPO mimetics for Indications Other Than ITP Use of TPO mimetics for Indications Other Than ITP Mazyar Shadman, MD, MPH Discussant: Siobán Keel, MD Hematology Fellows Conference June 28, 2013 Thrombopoietin (TPO) and other c mpl ligands TPO mimetics

More information

Complement Blockade with C1 Esterase Inhibitor in Refractory Immune Thrombocytopenia

Complement Blockade with C1 Esterase Inhibitor in Refractory Immune Thrombocytopenia THROMBOCYTOPENIA Complement Blockade with C1 Esterase Inhibitor in Refractory Immune Thrombocytopenia Erin Roesch, MD, and Catherine Broome, MD Abstract Immune thrombocytopenia (ITP) is a disease process

More information

Schematic Of Heparin Induced Thrombocytopenia Platelet Count

Schematic Of Heparin Induced Thrombocytopenia Platelet Count Schematic Of Heparin Induced Thrombocytopenia Platelet Count Normal IgG and IgG2 differentially inhibit HIT antibody-dependent platelet activation that platelet counts were lower in FcγRIIA 131RR patients

More information

Glomerular diseases mostly presenting with Nephritic syndrome

Glomerular diseases mostly presenting with Nephritic syndrome Glomerular diseases mostly presenting with Nephritic syndrome 1 The Nephritic Syndrome Pathogenesis: proliferation of the cells in glomeruli & leukocytic infiltrate Injured capillary walls escape of RBCs

More information

RaDaR Inclusion and Exclusion Criteria. Diagnosis Inclusion Criteria Exclusion Criteria. Alport Syndrome definite or probable

RaDaR Inclusion and Exclusion Criteria. Diagnosis Inclusion Criteria Exclusion Criteria. Alport Syndrome definite or probable Alport Syndrome and Type IV collagenopathies APRT Deficiency Alport Syndrome definite or probable Alport carrier definite or probable Thin basement membrane nephropathy APRT Deficiency confirmed Abolished

More information

The Oklahoma ITP Registry Newsletter July 2011

The Oklahoma ITP Registry Newsletter July 2011 The Oklahoma ITP Registry Newsletter July 2011 1 Hello! 1 The ITP Registry 1 Follow-Up Reminder 1 Dr. George s Perspective 3 Patient Stories: Rosie s Story 2010 Update 7 Send Your Suggestions 7 Resources

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium romiplostim, 250 microgram vial of powder for solution for subcutaneous injection (Nplate ) No. (553/09) Amgen 08 May 2009 (Issued 4 September 2009) The Scottish Medicines

More information